Objectives To explore the effect of escitalopram combined with aripiprazole on cognitive
function in patients with major depressive disorder (MDD), and to evaluate the clinical …

Objective To report side effect frequency and severity in patients with major depressive
disorder (MDD) receiving escitalopram and aripiprazole adjunctive therapy and to examine …

Background Anxiety symptoms usually worsen depression and functional impairment. The
present study was aimed to evaluate the impact of escitalopram on social function and …

Objective This study aimed to explore both impairments in attention function in patients with
major depressive disorder (MDD) and the efficacy of escitalopram monotherapy or …

Introduction Many individuals with major depressive disorder (MDD) do not respond to initial
antidepressant monotherapy. Adjunctive aripiprazole is recommended for treatment non …

Background: Somatic symptoms, which are common in major depressive disorder (MDD),
are associated with a worse prognosis and increased health costs. Aims: This randomized …

The aim of this study was to investigate the early effectiveness of adjunctive aripiprazole
treatment on the clinical symptoms and quality of life in patients with major depressive …

Background Significant anxiety symptoms are associated with poor clinical course and
outcome in major depressive disorder (MDD). This single-arm, open-label study aimed to …

Objective: This 7-week trial assessed the efficacy and tolerability of aripiprazole combined
with escitalopram in the acute treatment of major depressive disorder, with psychotic …

The aim of the study was to conduct a multicenter randomized double-blinded placebo-
controlled clinical study to evaluate the efficacy of a generic form of escitalopram in treating …